Influenza A virus (IAV) is the sole cause of the unpredictable influenza pandemics and
deadly zoonotic outbreaks and constitutes at least half of the cause of regular annual …

Please cite this paper as: McKimm‐Breschkin (2012) Influenza neuraminidase inhibitors:
Antiviral action and mechanisms of resistance. Influenza and Other Respiratory Viruses 7 …

These clinical practice guidelines are an update of the guidelines published by the
Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza …

Influenza is an acute respiratory disease caused by the influenza A or B virus. It often occurs
in outbreaks and epidemics worldwide, mainly during the winter season. Significant …

In addition to immunization programs, antiviral agents can play a major role for the control of
seasonal influenza epidemics and may also provide prophylactic and therapeutic benefits …

The world had been anticipating another influenza pandemic since the last one in 1968. The
pandemic influenza A H1N1 2009 virus (A/2009/H1N1) finally arrived, causing the first …

Objectives We compared the expelled air dispersion distances during coughing from a
human patient simulator (HPS) lying at 45° with and without wearing a surgical mask or N95 …

Summary Influenza A H1N1 2009 virus caused the first pandemic in an era when
neuraminidase inhibitor antiviral drugs were available in many countries. The experiences …

Influenza A virus (IAV) infection represents a global threat causing seasonal outbreaks and
pandemics. Additionally, secondary bacterial infections, caused mainly by Streptococcus …

Population (Sanger) sequencing has been the standard method in basic and clinical DNA
sequencing for almost 40 years; however, next-generation (deep) sequencing …